Drug Shortage Report for MYLAN-VARDENAFIL
| Report ID | 73041 |
| Drug Identification Number | 02464209 |
| Brand name | MYLAN-VARDENAFIL |
| Common or Proper name | VARDENAFIL tablets |
| Company Name | MYLAN PHARMACEUTICALS ULC |
| Market Status | MARKETED |
| Active Ingredient(s) | VARDENAFIL |
| Strength(s) | 5 mg |
| Dosage form(s) | Tablets |
| Route of administration | Oral |
| Packaging size | 4's |
| ATC code | G04BE |
| ATC description | Urologicals |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2019-01-17 |
| Estimated end date | 2020-05-19 |
| Actual end date | 2020-05-19 |
| Shortage status | Resolved |
| Updated date | 2020-05-20 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
| Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.